Lowest Price Guaranteed
Slides
174
Last Updated
July 2026
View Count
16136
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Detrimental Effects of Genotoxins / Mutagens
3.3. Mechanism of Genotoxicity / Mutagenicity
3.4. Techniques Employed for Genotoxicity Testing / Mutagenicity Testing
3.5. Applications of Genotoxicity / Mutagenicity
3.6. Recent Developments and Future Perspectives
4. MARKET LANDSCAPE
4.1. Genotoxicity Testing / Mutagenicity Testing Service Providers: Overall Market Landscape
4.1.1. Analysis by Type of Operation
4.1.2. Analysis by Type of Offering
4.1.3. Analysis by Regulatory Compliance
4.1.4. Analysis by Type of Assay(s)
4.1.5. Analysis by Assay(s) / Test(s) Offered
4.1.6. Analysis by End User Industry
4.1.7. Analysis by Type of Testing System(s)
4.1.8. Analysis by Custom Testing Services Offered
4.1.9. Analysis by Company Size and Type of Assay
4.1.10. Analysis by Assay / Test Offered and Type of Organization
4.2. Genotoxicity Testing / Mutagenicity Testing: Service Provider Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Type of Organization
4.2.5. Analysis by Location of Facility
5. BENCHMARKING ANALYSIS
5.1. Scope and Methodology
5.2. Assumptions and Key Parameters
5.3. Parameters Scoring
5.4. Benchmarking Analysis: Players based in North America
5.5. Benchmarking Analysis: Players based in Europe
5.6. Benchmarking Analysis: Players based in Asia-Pacific
6. COMPANY PROFILES
6.1. Aurigene Pharmaceutical Services
6.1.1. Company Overview
6.1.2. Service Portfolio
6.1.3. Recent Developments and Future Outlook
6.2. Charles River Laboratories
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Service Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. GLR Laboratories
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. LabCorp
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Service Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. LSIM Safety Institute
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Future Outlook
6.6. Sai Life Sciences
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Service Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Syngene
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Service Portfolio
6.7.4. Recent Developments and Future Outlook
7. PUBLICATION BENCHMARKING ANALYSIS
7.1. Scope and Methodology
7.2. Assumptions and Key Parameters
7.3. Analysis by Year of Publication
7.4. Analysis by Type of Article
7.5. Popular Journals: Analysis by Number of Publications
7.6. Popular Publishers: Analysis by Number of Publications
7.7. Analysis by Journal Impact Factor
7.8. Popular Journals: Analysis by Journal Impact Factor
7.9. Publication Timeline Analysis
7.10. Publication Benchmarking Methodology
7.11. Publication Benchmarking Analysis
7.12. List of Top 10 Publications
8. GRANTS ANALYSIS
8.1. Scope and Methodology
8.2. Assumptions and Key Parameters
8.3. Analysis by Year of Grant Award
8.4. Analysis by Amount Awarded
8.5. Analysis by Funding Institute Center
8.6. Analysis by Administering Institute Center
8.7. Analysis by Support Period
8.8. Popular Recipient Organizations: Analysis by Number of Grants
8.9. Analysis by Type of Recipient Organization
8.10. Analysis by Purpose of Grant
8.11. Analysis by Study Section
8.12. Popular NIH Departments: Analysis by Number of Grants
8.13. Analysis by Administering Institute Center and Support Period
8.14. Analysis by Type of Grant Application
8.15. Analysis by Grant Activity Code
8.16. Prominent Program Officers: Analysis by Number of Grants
8.17. Analysis by Location of Recipient Organization
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Partnership Models
9.2. Assumptions and Key Parameters
9.3. Genotoxicity Testing / Mutagenicity Testing: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partnership and Type of Partner
9.3.5. Analysis by Year of Partnership and Type of Partner
9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Analysis by Region
9.3.7.1. Intercontinental and Intracontinental Deals
9.3.8. Word Cloud Analysis: Emerging Focus Areas
10. PATENT ANALYSIS
10.1. Scope and Methodology
10.2. Assumptions and Key Parameters
10.3. Genotoxicity Testing and Mutagenicity Testing: List of Patents
10.4. Analysis by Type of Patent
10.5. Analysis by Patent Publication Year
10.6. Analysis by Annual Number of Granted Patents
10.7. Analysis by Geographical Location
10.8. Analysis by Jurisdiction
10.9. Analysis by CPC Symbols
10.10. Analysis by Type of Applicant
10.11. Analysis by Patent Age
10.12. Word Cloud: Emerging Focus Areas
10.13. Leading Industry Players: Analysis by Number of Patents
10.14. Leading Non-Industry Players: Analysis by Number of Patents
10.15. Leading Individual Assignees: Analysis by Number of Patents
10.16. Leading Players: Benchmarking by Patent Characterization (CPC Symbols)
10.17. Patent Valuation: Analysis Methodology and Parameters
10.17.1. Analysis by Relative Patent Valuation
11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Forecast Methodology and Key Assumptions
11.2. Global Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035
11.2.1. Genotoxicity Testing / Mutagenicity Testing Market: Analysis by Type of Assay, 2023 and 2035
11.2.1.1. Genotoxicity Testing / Mutagenicity Testing Market for In vivo Assays, 2023-2035
11.2.1.2. Genotoxicity Testing / Mutagenicity Testing Market for In vitro Assays, 2023-2035
11.2.1.3. Genotoxicity Testing / Mutagenicity Testing Market for Non-GLP / Screening Assays, 2023-2035
11.2.2. Genotoxicity Testing / Mutagenicity Testing Market: Analysis by Assay / Test Offered, 2023 and 2035
11.2.2.1. Genotoxicity Testing / Mutagenicity Testing Market for Comet Assays, 2023-2035
11.2.2.2. Genotoxicity Testing / Mutagenicity Testing Market for Micronucleus Assays, 2023-2035
11.2.2.3. Genotoxicity Testing / Mutagenicity Testing Market for Chromosomal Aberration Tests, 2023-2035
11.2.2.4. Genotoxicity Testing / Mutagenicity Testing Market for Genetic Mutation Tests, 2023-2035
11.2.2.5. Genotoxicity Testing / Mutagenicity Testing Market for Other Tests, 2023-2035
11.2.3. Genotoxicity Testing / Mutagenicity Testing Market: Analysis by End User Industry, 2023 and 2035
11.2.3.1. Genotoxicity Testing / Mutagenicity Testing Market for Chemical Industry 2023-2035
11.2.3.2. Genotoxicity Testing / Mutagenicity Testing Market for Healthcare Industry, 2023-2035
11.2.3.3. Genotoxicity Testing / Mutagenicity Testing Market for Agriculture Industry, 2023-2035
11.2.3.4. Genotoxicity Testing / Mutagenicity Testing Market for Cosmetic Industry, 2023-2035
11.2.3.5. Genotoxicity Testing / Mutagenicity Testing Market for Other Industries, 2023-2035
11.2.4. Genotoxicity Testing / Mutagenicity Testing Market: Analysis by Geographical Region, 2023 and 2035
11.2.4.1. Genotoxicity Testing / Mutagenicity Testing Market in North America, 2023-2035
11.2.4.2. Genotoxicity Testing / Mutagenicity Testing Market in Europe, 2023-2035
11.2.4.3. Genotoxicity Testing / Mutagenicity Testing Market in Asia-Pacific, 2023-2035
11.2.4.4. Genotoxicity Testing / Mutagenicity Testing Market in Latin America, 2023-2035
11.2.4.5. Genotoxicity Testing / Mutagenicity Testing Market in Middle East and North Africa, 2023-2035
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1 Detrimental Effects on Potential Targets of Genotoxins / Mutagens
Figure 3.2 Mechanism of Genotoxicity / Mutagenicity
Figure 4.1 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Operation
Figure 4.2 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Offering
Figure 4.3 Genotoxicity Testing / Mutagenicity Testing: Distribution by Regulatory Compliance
Figure 4.4 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Assay(s)
Figure 4.5 Genotoxicity Testing / Mutagenicity Testing: Distribution by Assay(s) / Test(s) Offered
Figure 4.6 Genotoxicity Testing / Mutagenicity Testing: Distribution by End User Industry
Figure 4.7 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Testing System(s)
Figure 4.8 Genotoxicity Testing / Mutagenicity Testing: Distribution by Custom Testing Services Offered
Figure 4.9 Genotoxicity Testing / Mutagenicity Testing: Distribution by Company Size and Type of Assay
Figure 4.10 Genotoxicity Testing / Mutagenicity Testing: Distribution by Assay Offered and Type of Organization
Figure 4.11 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Year of Establishment
Figure 4.12 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Company Size
Figure 4.13 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Location of Headquarters
Figure 4.14 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Type of Organization
Figure 4.15 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Location of Facility
Figure 5.1 Company Competitiveness: Players based in North America
Figure 5.2 Benchmarking Analysis: Leading Players in North America
Figure 5.3 Company Competitiveness: Players based in Europe
Figure 5.4 Benchmarking Analysis: Leading Players in Europe
Figure 5.5 Company Competitiveness: Players based in Asia-Pacific
Figure 5.6 Benchmarking Analysis: Leading Players in Asia-Pacific
Figure 6.1 Charles River Laboratories: Financial Information
Figure 6.2 LabCorp: Financial Information
Figure 6.3 Sai Life Sciences: Financial Information
Figure 6.4 Syngene: Financial Information
Figure 7.1 Publication Benchmarking: Distribution by Year of Publication
Figure 7.2 Publication Benchmarking: Distribution by Type of Article
Figure 7.3 Popular Journals: Distribution by Number of Publications
Figure 7.4 Popular Publishers: Distribution by Number of Publications
Figure 7.5 Publication Benchmarking: Distribution by Journal Impact Factor
Figure 7.6 Popular Journals: Distribution by Journal Impact Factor
Figure 7.7 Publication Timeline Analysis: Distribution by Article Type
Figure 7.8 Publication Timeline Analysis: Distribution by Journal Impact Factor
Figure 7.9 Publication Benchmarking Analysis
Figure 8.1 Grants Analysis: Distribution by Year of Grant Award
Figure 8.2 Grants Analysis: Distribution by Amount Awarded
Figure 8.3 Grants Analysis: Distribution by Funding Institute Center
Figure 8.4 Grants Analysis: Distribution by Administering Institute Center
Figure 8.5 Grants Analysis: Distribution by Support Period
Figure 8.6 Popular Recipient Organizations: Distribution by Number of Grants
Figure 8.7 Grants Analysis: Distribution by Type of Recipient Organization
Figure 8.8 Grants Analysis: Distribution by Purpose of Grant
Figure 8.9 Grants Analysis: Distribution by Study Section
Figure 8.10 Popular NIH Departments: Distribution by Number of Grants
Figure 8.11 Grants Analysis: Distribution by Administering Institute Center and Support Period
Figure 8.12 Grants Analysis: Distribution by Type of Grant Application
Figure 8.13 Grants Analysis: Distribution by Grant Activity Code
Figure 8.14 Prominent Program Officers: Distribution by Number of Grants
Figure 8.15 Grants Analysis: Distribution by Location of Recipient Organizations
Figure 9.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 9.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 9.6 Most Active Players: Distribution by Number of Partnerships
Figure 9.7 Partnerships and Collaborations: Distribution by Region
Figure 9.8 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 9.9 Word Cloud Analysis: Emerging Focus Areas
Figure 10.1 Patent Analysis: Distribution by Type of Patent
Figure 10.2 Patent Analysis: Distribution by Patent Publication Year
Figure 10.3 Patent Analysis: Distribution by Annual Number of Granted Patents
Figure 10.4 Patent Analysis: Distribution by Geographical Location
Figure 10.5 Patent Analysis: Distribution by Patent Jurisdiction
Figure 10.6 Patent Analysis: Distribution by CPC Symbols
Figure 10.7 Patent Analysis: Distribution by Type of Applicant
Figure 10.8 Patent Analysis: Distribution by Patent Age
Figure 10.9 Word Cloud: Emerging Focus Areas
Figure 10.10 Leading Industry Players: Distribution by Number of Patents
Figure 10.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 10.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 10.13 Leading Players: Benchmarking by Patent Characterization (CPC Symbols)
Figure 10.14 Patent Valuation: Distribution by Relative Patent Valuation
Figure 11.1 Global Genotoxicity Testing / Mutagenicity Testing Market, 20232-2035 (USD Million)
Figure 11.2 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by Type of Assay
Figure 11.3 Genotoxicity Testing / Mutagenicity Testing Market for In vivo Assays, 2023-2035 (USD Million)
Figure 11.4 Genotoxicity Testing / Mutagenicity Testing Market for In vitro Assays, 2023-2035 (USD Million)
Figure 11.5 Genotoxicity Testing / Mutagenicity Testing Market for Non-GLP / Screening Assays, 2023-2035 (USD Million)
Figure 11.6 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by Assay / Test Offered
Figure 11.7 Genotoxicity Testing / Mutagenicity Testing Market for Comet Assays, 2023-2035 (USD Million)
Figure 11.8 Genotoxicity Testing / Mutagenicity Testing Market for Micronucleus Assays, 2023-2035 (USD Million)
Figure 11.9 Genotoxicity Testing / Mutagenicity Testing Market for Chromosomal Aberration Tests, 2023-2035 (USD Million)
Figure 11.10 Genotoxicity Testing / Mutagenicity Testing Market for Genetic Mutation Tests, 2023-2035 (USD Million)
Figure 11.11 Genotoxicity Testing / Mutagenicity Testing Market for Other Tests, 2023-2035 (USD Million)
Figure 11.12 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by End User Industry
Figure 11.13 Genotoxicity Testing / Mutagenicity Testing Market for Chemical Industry, 2023-2035 (USD Million)
Figure 11.14 Genotoxicity Testing / Mutagenicity Testing Market for Healthcare Industry, 2023-2035 (USD Million)
Figure 11.15 Genotoxicity Testing / Mutagenicity Testing Market for Agriculture Industry, 2023-2035 (USD Million)
Figure 11.16 Genotoxicity Testing / Mutagenicity Testing Market for Cosmetic Industry, 2023-2035 (USD Million)
Figure 11.17 Genotoxicity Testing / Mutagenicity Testing Market for Other Industries, 2023-2035 (USD Million)
Figure 11.18 Genotoxicity Testing / Mutagenicity Testing Market, 2023 and 2035: Distribution by Geographical Region
Figure 11.19 Genotoxicity Testing / Mutagenicity Testing Market in North America, 2023-2035 (USD Million)
Figure 11.20 Genotoxicity Testing / Mutagenicity Testing Market in Europe, 2023-2035 (USD Million)
Figure 11.21 Genotoxicity Testing / Mutagenicity Testing Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 11.22 Genotoxicity Testing / Mutagenicity Testing Market in Latin America, 2023-2035 (USD Million)
Figure 11.23 Genotoxicity Testing / Mutagenicity Testing Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 3.1 Standard Test for Genotoxicity
Table 4.1 List of Genotoxicity / Mutagenicity Testing Service Providers
Table 6.1 Aurigene Pharmaceutical Services: Service Portfolio
Table 6.2 Aurigene Pharmaceutical Services: Recent Developments and Future Outlook
Table 6.3 Charles River Laboratories: Service Portfolio
Table 6.4 Charles River Laboratories: Recent Developments and Future Outlook
Table 6.5 GLR Laboratories: Service Portfolio
Table 6.6 GLR Laboratories: Recent Developments and Future Outlook
Table 6.7 LabCorp: Service Portfolio
Table 6.8 LabCorp: Recent Developments and Future Outlook
Table 6.9 LSIM Safety Institute: Service Portfolio
Table 6.10 LSIM Safety Institute: Future Outlook
Table 6.11 Sai Life Sciences: Service Portfolio
Table 6.12 Sai Life Sciences: Recent Developments and Future Outlook
Table 6.13 Syngene: Service Portfolio
Table 6.14 Syngene: Recent Developments and Future Outlook
Table 7.1 Genotoxicity / Mutagenicity Testing: List of Publications
Table 7.2 List of Top 10 Publications
Table 8.1 Genotoxicity Testing / Mutagenicity Testing: List of Grants
Table 9.1 Genotoxicity Testing / Mutagenicity Testing Services: List of Partnerships and Collaborations
Table 10.1 Genotoxicity Testing / Mutagenicity Testing: List of Patents
Table 12.1 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Operation
Table 12.2 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Offering
Table 12.3 Genotoxicity Testing / Mutagenicity Testing: Distribution by Regulatory Compliance
Table 12.4 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Assay(s)
Table 12.5 Genotoxicity Testing / Mutagenicity Testing: Distribution by Assay(s) / Test(s) Offered
Table 12.6 Genotoxicity Testing / Mutagenicity Testing: Distribution by End User Industry
Table 12.7 Genotoxicity Testing / Mutagenicity Testing: Distribution by Type of Testing System(s)
Table 12.8 Genotoxicity Testing / Mutagenicity Testing: Distribution by Custom Testing Services Offered
Table 12.9 Genotoxicity Testing / Mutagenicity Testing: Distribution by Company Size and Type of Assay
Table 12.10 Genotoxicity Testing / Mutagenicity Testing: Distribution by Assay / Test Offered and Type of Organization
Table 12.11 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Year of Establishment
Table 12.12 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Company Size
Table 12.13 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Location of Headquarters
Table 12.14 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Type of Organization
Table 12.15 Genotoxicity Testing / Mutagenicity Testing Service Providers: Distribution by Location of Facility
Table 12.16 Charles River Laboratories: Financial Information
Table 12.17 LabCorp: Financial Information
Table 12.18 Syngene: Financial Information
Table 12.19 Sai Life Sciences: Financial Information
Table 12.20 Publication Benchmarking: Distribution by Year of Publication
Table 12.21 Publication Benchmarking: Distribution by Type of Article
Table 12.22 Popular Journals: Distribution by Number of Publications
Table 12.23 Popular Publishers: Distribution by Number of Publications
Table 12.24 Publication Benchmarking: Distribution by Journal Impact Factor
Table 12.25 Popular Journals: Distribution by Journal Impact Factor
Table 12.26 Grants Analysis: Distribution by Year of Grant Award
Table 12.27 Grants Analysis: Distribution by Amount Awarded
Table 12.28 Grants Analysis: Distribution by Funding Institute Center
Table 12.29 Grants Analysis: Distribution by Administering Institute Center
Table 12.30 Grants Analysis: Distribution by Support Period
Table 12.31 Popular Recipient Organization: Distribution by Number of Grants
Table 12.32 Grants Analysis: Distribution by Type of Recipient Organization
Table 12.33 Grants Analysis: Distribution by Purpose of Grant
Table 12.34 Grants Analysis: Distribution by Study Section
Table 12.35 Popular NIH Departments: Distribution by Number of Grants
Table 12.36 Grants Analysis: Distribution by Administering Institute Center and Support Period
Table 12.37 Grants Analysis: Distribution by Type of Type of Grant Application
Table 12.38 Grants Analysis: Distribution by Grant Activity Code
Table 12.39 Prominent Program Officers: Distribution by Number of Grants
Table 12.40 Grants Analysis: Distribution by Location of Recipient Organization
Table 12.41 Partnerships and Collaborations: Distribution by Year of Partnership
Table 12.42 Partnerships and Collaborations: Distribution by Type of Partnership
Table 12.43 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 12.44 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 12.45 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 12.46 Most Active Players: Distribution by Number of Partnerships
Table 12.47 Partnerships and Collaborations: Distribution by Region
Table 12.48 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Table 12.49 Patent Analysis: Distribution by Type of Patent
Table 12.50 Patent Analysis: Distribution by Patent Publication Year
Table 12.51 Patent Analysis: Distribution by Annual Number of Granted Patents
Table 12.52 Patent Analysis: Distribution by Geographical Location
Table 12.53 Patent Analysis: Distribution by Jurisdiction
Table 12.54 Patent Analysis: Distribution by Type of Applicant
Table 12.55 Patent Analysis: Distribution by Patent Age
Table 12.56 Leading Industry Players: Distribution by Number of Patents
Table 12.57 Leading Non-Industry Players: Distribution by Number of Patents
Table 12.58 Leading Individual Assignees: Distribution by Number of Patents
Table 12.59 Patent Valuation: Distribution by Relative Valuation
Table 12.60 Global Genotoxicity Testing / Mutagenicity Testing Market, 20232-2035 (USD Million)
Table 12.61 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by Type of Assay
Table 12.62 Genotoxicity Testing / Mutagenicity Testing Market for In vivo Assays, 2023-2035 (USD Million)
Table 12.63 Genotoxicity Testing / Mutagenicity Testing Market for In vitro Assays, 2023-2035 (USD Million)
Table 12.64 Genotoxicity Testing / Mutagenicity Testing Market for Non-GLP / Screening Assays, 2023-2035 (USD Million)
Table 12.65 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by Assay / Test Offered
Table 12.66 Genotoxicity Testing / Mutagenicity Testing Market for Comet Assays, 2023-2035 (USD Million)
Table 12.67 Genotoxicity Testing / Mutagenicity Testing Market for Micronucleus Assays, 2023-2035 (USD Million)
Table 12.68 Genotoxicity Testing / Mutagenicity Testing Market for Chromosomal Aberration Tests, 2023-2035 (USD Million)
Table 12.69 Genotoxicity Testing / Mutagenicity Testing Market for Genetic Mutation Tests, 2023-2035 (USD Million)
Table 12.70 Genotoxicity Testing / Mutagenicity Testing Market for Other Tests, 2023-2035 (USD Million)
Table 12.71 Genotoxicity Testing / Mutagenicity Testing Market, 2023-2035: Distribution by End User Industry
Table 12.72 Genotoxicity Testing / Mutagenicity Testing Market for Chemical Industry, 2023-2035 (USD Million)
Table 12.73 Genotoxicity Testing / Mutagenicity Testing Market for Healthcare Industry, 2023-2035 (USD Million)
Table 12.74 Genotoxicity Testing / Mutagenicity Testing Market for Agriculture Industry, 2023-2035 (USD Million)
Table 12.75 Genotoxicity Testing / Mutagenicity Testing Market for Cosmetic Industry, 2023-2035 (USD Million)
Table 12.76 Genotoxicity Testing / Mutagenicity Testing Market for Other Industries, 2023-2035 (USD Million)
Table 12.77 Genotoxicity Testing / Mutagenicity Testing Market, 2023 and 2035: Distribution by Geographical Region
Table 12.78 Genotoxicity Testing / Mutagenicity Testing Market in North America, 2023-2035 (USD Million)
Table 12.79 Genotoxicity Testing / Mutagenicity Testing Market in Europe, 2023-2035 (USD Million)
Table 12.80 Genotoxicity Testing / Mutagenicity Testing Market in Asia-Pacific, 2023-2035 (USD Million)
Table 12.81 Genotoxicity Testing / Mutagenicity Testing Market in Latin America, 2023-2035 (USD Million)
Table 12.82 Genotoxicity Testing / Mutagenicity Testing Market in Middle East and North Africa, 2023-2035 (USD Million)
Please reach out to our team for the details.
Source 1: https://www.news-medical.net/life-sciences/What-is-Genotoxicity-Testing.aspx
Source 2: https://pubmed.ncbi.nlm.nih.gov/19157059/